SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-136547
Filing Date
2020-12-17
Accepted
2020-12-17 06:07:59
Documents
1
Period of Report
2020-12-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2038660d2_4.html 4  
1 OWNERSHIP DOCUMENT tm2038660d2_4.xml 4 4260
  Complete submission text file 0001104659-20-136547.txt   5995
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Issuer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GRITSTONE ONCOLOGY, INC. 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608
Business Address
Bellemin Jean-Marc (Reporting) CIK: 0001754253 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36860 | Film No.: 201394153